Filter posts

Dealing with Rejection, the Regulatory Kind

The ubiquitous CRL in biotech has made its way into the news headlines again. But …

What Parallel Review Means for Manufacturers

By Stephen Rothenberg, J.D. and Matt Levy, J.D., Numerof & Associates, Inc. (NAI) Currently, the …

Update: Indices, IPOs, and New Drug Approvals

Here is a look at year to date (YTD) numbers through the end of February …

Reviewing the drug class of 2011

The drug class of 2011 was larger than the past few graduating classes. We count …

The Ethics of Global Clinical Trials

By Dr. Russell Medford,┬áSalutria Pharmaceuticals Recent reports have raised concerns about how clinical trials are …

Boosting Investment in Biotech

The President’s Council on Jobs and Competitiveness issued an interim report with suggestions to increase …

Is Animal Biotechnology Progressing?

By David Edwards, PhD Director, Animal Biotechnology, BIO One year ago, I was pleased to …

Evolution of Biotech Industry is a Constant

Healthcare being delivered by smartphone, homes containing treatment capabilities now only found in hospitals, groundbreaking …

Unleashing the Promise of Biotechnology to Cure Disease and Save Lives

The other day I came across an article discussing vaccinations and the author mentioned his …

New Era in Animal Biotechnology: FDA Approves Therapy Produced with Genetically Engineered Goats

As an animal scientist, today is an exciting day in my career. I know first-hand …